---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-005165"
form_type: "8-K"
ticker: "VVOS"
cik: "0001716166"
company_name: "Vivos Therapeutics, Inc."
filed_at: "2025-04-17T23:59:59+00:00"
generated_at: "2026-05-23T11:58:27.748193+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Vivos Therapeutics signs $9M deal to acquire Nevada sleep center operator SCN

## Summary
- Total consideration up to $9M: $6M cash + $1.5M stock at closing + $1.5M stock earn-out.
- SCN sees ~3,000 new patients/month; annual revenue in high seven figures; 7 locations in Nevada.
- Close expected Q2/Q3 2025, subject to financing, audit, and customary conditions; no shareholder vote needed.
- Employment agreement for Dr. Rachakonda includes $400K salary and board observation right; New Seneca Partners assisted.

## SEC filing metadata
- accession: 0001641172-25-005165
- form_type: 8-K
- ticker: VVOS
- cik: 0001716166
- company_name: Vivos Therapeutics, Inc.
- filed_at: 2025-04-17T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716166/000164117225005165/0001641172-25-005165-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716166/000164117225005165/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-005165
- JSON: https://secwatch.observer/filing/0001641172-25-005165.json
- Plain text: https://secwatch.observer/filing/0001641172-25-005165.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.